Delivery Order SPE2DB22D3301-SPE2DB26FX4PK
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,948.10 to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a delivery order valued at $5,080.98 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on August 27, 2025, with completion scheduled for August 28, 2025. This non-set-aside, firm fixed-price delivery order represents a pharmaceutical procurement supporting federal medical supply needs. The award was issued to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $2,980.71 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on November 3, 2025, with completion targeted for November 4, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor at its corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger indefinite delivery contract...
- The Defense Logistics Agency awarded a $2,511.19 delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Vemlidy 25 mg tablets (30-count units). This is a firm fixed-price delivery order with an ultimate completion date of October 22, 2025, and carries no set-aside designation, indicating it was competitively awarded. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a $7,245.84 delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Vemlidy 25 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of June 2, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $7,426.36 delivery order to AmerisourceBergen Drug Corp for 30 tablets of Vemlidy 25 mg on November 4, 2025, with completion scheduled for November 5, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a single delivery order under AmerisourceBergen's existing pharmaceutical supply agreement with DLA. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded a delivery order valued at $5,823.97 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets in a quantity of 30 units. The contract, awarded on November 7, 2025, with an ultimate completion date of November 10, 2025, is structured as a firm fixed price delivery order with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $10,560.80 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, the pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, on July 21, 2025, for the supply of Vemlidy 25 mg tablets (30-count units) with a ceiling value of $5,656.80. This is a firm fixed-price delivery order with an ultimate completion date of July 22, 2025, issued with no set-aside designation, indicating the award was competitively awarded. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $5,542.33 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-tablet units) on September 19, 2025, with completion scheduled for September 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning the award was made through open competition. The pharmaceutical will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB26FX4PKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,480.24 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on November 10, 2025, with completion scheduled for November 12, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary distribution operations. This delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military healthcare systems and other government agencies. The award reflects the contractor's established capability to meet federal procurement requirements and its ongoing role as a primary pharmaceutical supplier within the DLA's Medical Supply Chain supporting Defense Health Agency operations and other federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 11/10/25 |